Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

811
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
811
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

688
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
688
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

688
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
688
Actuarial Approach01:20

Actuarial Approach

354
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
354

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Outcomes of Epidural Motor Cortex Stimulation for Refractory Chronic Neuropathic Orofacial Pain.

Life (Basel, Switzerland)·2026
Same author

Dynamics of Inflammatory Parameters in Hospitalized and Surgically Treated Patients with Odontogenic Abscesses.

Medicina (Kaunas, Lithuania)·2026
Same author

Voice Change Following Third Molar Alveolectomy: A Rare and Preventable Complication.

Dentistry journal·2026
Same author

C-Reactive Protein-to-Platelet Inflammatory Index (CPII) and Symptom Severity Score for Early Differentiation of Odontogenic Cervicofacial Necrotizing Fasciitis from Odontogenic Abscesses: A Retrospective Cohort Study.

Dentistry journal·2026
Same author

Non-Smoking, Non-Drinking Oral Squamous Cell Carcinoma Is Associated with an Immune-Modulated Clinical Phenotype.

Cancers·2026
Same author

Revisiting Rosacea Through the Skin-Gut-Brain Axis: A Neuroimmune Perspective.

Life (Basel, Switzerland)·2026

Related Experiment Video

Updated: Mar 15, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K

Persistent Long-Term Risk After Primary Surgery for Head and Neck Adenoid Cystic Carcinoma: Competing-Risk and

Ivica Lukšić1,2, Marko Tarle1,3, Marina Raguž4,5

  • 1Department of Maxillofacial and Oral Surgery, Dubrava University Hospital, 10000 Zagreb, Croatia.

Cancers
|March 14, 2026
PubMed
Summary

Head and neck adenoid cystic carcinoma (HNAdCC) patients face a persistent long-term risk of recurrence and death, with many failures occurring after five years. Lifelong surveillance is recommended to detect late distant metastases.

Keywords:
adenoid cystic carcinomahead and neck cancerlong-term follow-upsalivary gland neoplasmssurvival analysis

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

988
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Related Experiment Videos

Last Updated: Mar 15, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

11.0K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

988
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Area of Science:

  • Oncology
  • Head and Neck Surgery
  • Cancer Epidemiology

Background:

  • Head and neck adenoid cystic carcinoma (HNAdCC) has an indolent growth pattern but carries a sustained risk of late recurrence and mortality.
  • Limited data exist on very long-term outcomes, especially when accounting for competing mortality risks.

Purpose of the Study:

  • To characterize late failure patterns in HNAdCC.
  • To analyze competing causes of death.
  • To provide clinically interpretable long-horizon risk estimates after primary surgery for HNAdCC.

Main Methods:

  • Retrospective single-center cohort study of HNAdCC patients treated with curative-intent surgery (1984-2020).
  • Kaplan-Meier method for Overall Survival (OS) and Cancer-Specific Survival (CSS).
  • Cumulative incidence functions for competing risks and failure patterns, including a 5-year landmark analysis; Conditional mortality and Restricted Mean Survival Time (RMST) assessed.

Main Results:

  • Of 57 patients, 33.3% experienced first failure, with distant metastasis being most common; 36.8% of failures occurred beyond 5 years.
  • At 25 years, OS was 37.5% and CSS was 51.7%. Cumulative incidence of disease-related death was 41.7% versus 20.9% for other-cause death.
  • Older age, advanced T category, and perineural invasion were associated with worse survival outcomes; conditional risk of disease-related death by 25 years remained 32.7% for 5-year survivors.

Conclusions:

  • HNAdCC presents a persistent long-term risk with significant late failures and competing mortality over decades.
  • Conditional and RMST estimates offer patient-centered metrics supporting lifelong, risk-adapted surveillance.
  • Surveillance should focus on detecting distant metastases due to their high occurrence late in the disease course.